Cargando…
SPTBN1 abrogates renal clear cell carcinoma progression via glycolysis reprogramming in a GPT2-dependent manner
BACKGROUND: Renal clear cell carcinoma (ccRCC) is the most prevalent tumors worldwide. Discovering effective biomarkers is essential to monitor the prognosis and provide alternative clinical options. SPTBN1 is implicated in various cancerous processes. However, its role in ccRCC remains unelucidated...
Autores principales: | Wu, Jiajin, Miao, Chenkui, Wang, Yuhao, Wang, Songbo, Wang, Zhongyuan, Liu, Yiyang, Wang, Xiaoyi, Wang, Zengjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9756479/ https://www.ncbi.nlm.nih.gov/pubmed/36527113 http://dx.doi.org/10.1186/s12967-022-03805-w |
Ejemplares similares
-
Integrated single-cell and bulk characterization of cuproptosis key regulator PDHB and association with tumor microenvironment infiltration in clear cell renal cell carcinoma
por: Wu, Jiajin, et al.
Publicado: (2023) -
Essential m(6)A Methylation Regulator HNRNPC Serves as a Targetable Biomarker for Papillary Renal Cell Carcinoma
por: Wu, Jiajin, et al.
Publicado: (2022) -
Comprehensive Analysis of m(5)C RNA Methylation Regulator Genes in Clear Cell Renal Cell Carcinoma
por: Wu, Jiajin, et al.
Publicado: (2021) -
Emerging Roles of Circ-ZNF609 in Multiple Human Diseases
por: Wang, Songbo, et al.
Publicado: (2022) -
High expression of CDCA7 predicts poor prognosis for clear cell renal cell carcinoma and explores its associations with immunity
por: Liu, Shouyong, et al.
Publicado: (2021)